Molecular classification identifies a subset of human papillomavirus- associated oropharyngeal cancers with favorable prognosis

Journal of Clinical Oncology

Volumn 24, Issue 5, 2006, Pages 736-747

  Weinberger, Paul M ^a   Yu, Ziwei ^a   Haffty, Bruce G ^a   Kowalski, Diane ^a   Harigopal, Malini ^a   Brandsma, Janet ^a   Sasaki, Clarence ^a   Joe, John ^a   Camp, Robert L ^a   Rimm, David L ^a   Psyrri, Amanda ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN E7; PROTEIN P16; PROTEIN P53; RETINOBLASTOMA PROTEIN; VIRUS DNA;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; FEMALE; FOLLOW UP; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OROPHARYNX CARCINOMA; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; TUMOR CLASSIFICATION; VIRUS LOAD; CLASSIFICATION; COHORT ANALYSIS; GENETICS; MIDDLE AGED; OROPHARYNX TUMOR; PATHOGENICITY; PATHOLOGY; POLYMERASE CHAIN REACTION; SURVIVAL; VIROLOGY; VIRUS INFECTION;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; DNA, VIRAL; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMANS; MALE; MIDDLE AGED; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PREVALENCE; PROGNOSIS; SURVIVAL ANALYSIS; VIRAL LOAD;

EID: 33644849030     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2004.00.3335     Document Type: Article

References (39)

1. Andl T, Kahn T, Pfuhl A, et al: Etiological involvement of oncogenic human papillomavirus in tonsillar squamous cell carcinomas lacking retinoblastoma cell cycle control. Cancer Res 58:5-13, 1998
2. Gillison ML, Koch WM, Capone RB, et al: Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 92:709-720, 2000
3. Frisch M, Biggar RJ: Aetiological parallel between tonsillar and anogenital squamous-cell carcinomas. Lancet 354:1442-1443, 1999
4. Swoboda A, Fabrizii V: Tonsillar carcinoma in a renal graft recipient treated with cyclosporine A. Clin Nephrol 39:272-274, 1993
5. de Villiers EM, Weidauer H, Otto H, et al: Papillomavirus DNA in human tongue carcinomas. Int J Cancer 36:575-578, 1985
6. Franceschi S, Munoz N, Bosch XF, et al: Human papillomavirus and cancers of the upper aerodigestive tract: A review of epidemiological and experimental evidence. Cancer Epidemiol Biomarkers Prev 5:567-575, 1996
7. Snijders PJ, Scholes AG, Hart CA, et al: Prevalence of mucosotropic human papillomaviruses in squamous-cell carcinoma of the head and neck. Int J Cancer 66:464-469, 1996
8. McKaig RG, Baric RS, Olshan AF: Human papillomavirus and head and neck cancer: Epidemiology and molecular biology. Head Neck 20:250-265, 1998
9. Psyrri A, DeFilippis RA, Edwards AP, et al: Role of the retinoblastoma pathway in senescence triggered by repression of the human papillomavirus E7 protein in cervical carcinoma cells. Cancer Res 64:3079-3086, 2004
10. Alani RM, Munger K: Human papillomaviruses and associated malignancies. J Clin Oncol 16:330-337, 1998
11. Serrano M, Hannon GJ, Beach D: A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366:704-707, 1993
12. Agoff SN, Lin P, Morihara J, et al: P16(INK4a) expression correlates with degree of cervical neoplasia: A comparison with Ki-67 expression and detection of high-risk HPV types. Mod Pathol 16: 665-673, 2003
13. Begum S, Gillison ML, Ansari-Lari MA, et al: Detection of human papillomavirus in cervical lymph nodes: A highly effective strategy for localizing site of tumor origin. Clin Cancer Res 9:6469-6475, 2003
14. Cairns P, Mao L, Merlo A, et al: Rates of p16 (MTS1) mutations in primary tumors with 9p loss. Science 265:415-417, 1994
15. Merlo A, Herman JG, Mao L, et al: 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/ MTS1 in human cancers. Nat Med 1:686-692, 1995
16. Reed AL, Califano J, Cairns P, et al: High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. Cancer Res 56:3630-3633, 1996
17. Weinberger PM, Yu Z, Haffty BG, et al: Prognostic significance of p16 protein levels in oropharyngeal squamous cell cancer. Clin Cancer Res 10:5684-5691, 2004
18. Haraf DJ, Nodzenski E, Brachman D, et al: Human papilloma virus and p53 in head and neck cancer: Clinical correlates and survival. Clin Cancer Res 2:755-762, 1996
19. Brandwein M, Zeitlin J, Nuovo GJ, et al: HPV detection using "hot start" polymerase chain reaction in patients with oral cancer: A clinicopathological study of 64 patients. Mod Pathol 7:720-727, 1994
20. Klussmann JP, Weissenborn SJ, Wieland U, et al: Human papillomavirus-positive tonsillar carcinomas: A different tumor entity? Med Microbiol Immunol (Berl) 192:129-132, 2003
21. Strome SE, Savva A, Brissett AE, et al: Squamous cell carcinoma of the tonsils: A molecular analysis of HPV associations. Clin Cancer Res 8:1093-1100, 2002
22. Li W, Thompson CH, O'Brien CJ, et al: Human papillomavirus positivity predicts favourable outcome for squamous carcinoma of the tonsil. Int J Cancer 106:553-558, 2003
23. Koskinen WJ, Chen RW, Leivo I, et al: Prevalence and physical status of human papillomavirus in squamous cell carcinomas of the head and neck. Int J Cancer 107:401-406, 2003
24. Coombs NJ, Gough AC, Primrose JN: Optimisation of DNA and RNA extraction from archival formalin-fixed tissue. Nucleic Acids Res 27:15, 1999
25. Camp RL, Chung GG, Rimm DL: Automated subcellular localization and quantification of protein expression in tissue microarrays. Nat Med 8:1323-1327, 2002
26. McDougall JK: Immortalization and transformation of human cells by human papillomavirus. Curr Top Microbiol Immunol 186:101-119, 1994
27. Braakhuis BJ, Snijders PJ, Keune WJ, et al: Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus. J Natl Cancer Inst 96:998-1006, 2004
28. Dai M, Clifford GM, le Calvez F, et al: Human papillomavirus type 16 and TP53 mutation in oral cancer: Matched analysis of the IARC multicenter study. Cancer Res 64:468-471, 2004
29. Koch WM, Lango M, Sewell D, et al: Head and neck cancer in nonsmokers: A distinct clinical and molecular entity. Laryngoscope 109:1544-1551, 1999
30. Ritchie JM, Smith EM, Summersgill KF, et al: Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx. Int J Cancer 104:336-344, 2003
31. Klussmann JP, Gultekin E, Weissenborn SJ, et al: Expression of p16 protein identifies a distinct entity of tonsillar carcinomas associated with human papillomavirus. Am J Pathol 162:747-753, 2003
32. Paz IB, Cook N, Odom-Maryon T, et al: Human papillomavirus (HPV) in head and neck cancer: An association of HPV 16 with squamous cell carcinoma of Waldeyer's tonsillar ring. Cancer 79:595-604, 1997
33. Ringstrom E, Peters E, Hasegawa M, et al: Human papillomavirus type 16 and squamous cell carcinoma of the head and neck. Clin Cancer Res 8:3187-3192, 2002
34. Schwartz SR, Yueh B, McDougall JK, et al: Human papillomavirus infection and survival in oral squamous cell cancer: A population-based study. Otolaryngol Head Neck Surg 125:1-9, 2001
35. Stein GH, Drullinger LF, Soulard A, et al: Differential roles for cyclin-dependent kinase inhibitors p21 and p16 in the mechanisms of senescence and differentiation in human fibroblasts. Mol Cell Biol 19:2109-2117, 1999
36. Alcorta DA, Xiong Y, Phelps D, et al: Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts. Proc Natl Acad Sci U S A 93:13742-13747, 1996
37. Mellin H, Dahlgren L, Munck-Wikland E, et al: Human papillomavirus type 16 is episomal and a high viral load may be correlated to better prognosis in tonsillar cancer. Int J Cancer 102:152-158, 2002
38. Van Tine BA, Dao LD, Wu SY, et al: Human papillomavirus (HPV) origin-binding protein associates with mitotic spindles to enable viral DNA partitioning. Proc Natl Acad Sci U S A 101:4030-4035, 2004
39. Nuovo GJ, Plaia TW, Belinsky SA, et al: In situ detection of the hypermethylation-induced inactivation of the p16 gene as an early event in oncogenesis. Proc Natl Acad Sci U S A 96:12754-12759, 1999